The Company needs to conserve cash, which clearly was not happening with DG. Hence if 16 gives the data needed, no point in spending extra for little information gain from 15.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025